RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Jerzy Leszczynski to Animals

This is a "connection" page, showing publications Jerzy Leszczynski has written about Animals.
Connection Strength

1.220
  1. Toropova AP, Toropov AA, Roncaglioni A, Benfenati E, Leszczynska D, Leszczynski J. CORAL: Model of Ecological Impact of Heavy Metals on Soils via the Study of Modification of Concentration of Biomolecules in Earthworms (Eisenia fetida). Arch Environ Contam Toxicol. 2023 May; 84(4):504-515.
    View in: PubMed
    Score: 0.069
  2. Kar S, Roy K, Leszczynski J. In Silico Tools and Software to Predict ADMET of New Drug Candidates. Methods Mol Biol. 2022; 2425:85-115.
    View in: PubMed
    Score: 0.063
  3. Ojha PK, Kar S, Krishna JG, Roy K, Leszczynski J. Therapeutics for COVID-19: from computation to practices-where we are, where we are heading to. Mol Divers. 2021 Feb; 25(1):625-659.
    View in: PubMed
    Score: 0.058
  4. Kar S, Leszczynski J. Open access in silico tools to predict the ADMET profiling of drug candidates. Expert Opin Drug Discov. 2020 12; 15(12):1473-1487.
    View in: PubMed
    Score: 0.057
  5. Kar S, Leszczynski J. Is intraspecies QSTR model answer to toxicity data gap filling: Ecotoxicity modeling of chemicals to avian species. Sci Total Environ. 2020 Oct 10; 738:139858.
    View in: PubMed
    Score: 0.057
  6. Toropov AA, Toropova AP, Leszczynska D, Leszczynski J. "Ideal correlations" for biological activity of peptides. Biosystems. 2019 Jul; 181:51-57.
    View in: PubMed
    Score: 0.052
  7. Khan K, Kar S, Sanderson H, Roy K, Leszczynski J. Ecotoxicological Modeling, Ranking and Prioritization of Pharmaceuticals Using QSTR and i-QSTTR Approaches: Application of 2D and Fragment Based Descriptors. Mol Inform. 2019 08; 38(8-9):e1800078.
    View in: PubMed
    Score: 0.051
  8. Kar S, Ghosh S, Leszczynski J. Single or mixture halogenated chemicals? Risk assessment and developmental toxicity prediction on zebrafish embryos based on weighted descriptors approach. Chemosphere. 2018 Nov; 210:588-596.
    View in: PubMed
    Score: 0.050
  9. Kar S, Roy K, Leszczynski J. Impact of Pharmaceuticals on the Environment: Risk Assessment Using QSAR Modeling Approach. Methods Mol Biol. 2018; 1800:395-443.
    View in: PubMed
    Score: 0.048
  10. Gooch A, Sizochenko N, Rasulev B, Gorb L, Leszczynski J. In vivo toxicity of nitroaromatics: A comprehensive quantitative structure-activity relationship study. Environ Toxicol Chem. 2017 08; 36(8):2227-2233.
    View in: PubMed
    Score: 0.045
  11. Gooch A, Sizochenko N, Sviatenko L, Gorb L, Leszczynski J. A quantum chemical based toxicity study of estimated reduction potential and hydrophobicity in series of nitroaromatic compounds. SAR QSAR Environ Res. 2017 Feb; 28(2):133-150.
    View in: PubMed
    Score: 0.045
  12. Kar S, Leszczynski J. Recent Advances of Computational Modeling for Predicting Drug Metabolism: A Perspective. Curr Drug Metab. 2017; 18(12):1106-1122.
    View in: PubMed
    Score: 0.045
  13. Toropova AP, Toropov AA, Veselinovic AM, Veselinovic JB, Leszczynska D, Leszczynski J. Monte Carlo-based quantitative structure-activity relationship models for toxicity of organic chemicals to Daphnia magna. Environ Toxicol Chem. 2016 11; 35(11):2691-2697.
    View in: PubMed
    Score: 0.043
  14. Toropova AP, Toropov AA, Benfenati E, Leszczynska D, Leszczynski J. QSAR model as a random event: A case of rat toxicity. Bioorg Med Chem. 2015 Mar 15; 23(6):1223-30.
    View in: PubMed
    Score: 0.039
  15. Turabekova MA, Rasulev BF, Dzhakhangirov FN, Toropov AA, Leszczynska D, Leszczynski J. Aconitum and delphinium diterpenoid alkaloids of local anesthetic activity: comparative QSAR analysis based on GA-MLRA/PLS and optimal descriptors approach. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2014; 32(3):213-38.
    View in: PubMed
    Score: 0.036
  16. Toropov AA, Toropova AP, Raska I, Leszczynska D, Leszczynski J. Comprehension of drug toxicity: software and databases. Comput Biol Med. 2014 Feb; 45:20-5.
    View in: PubMed
    Score: 0.036
  17. Gajewicz A, Rasulev B, Dinadayalane TC, Urbaszek P, Puzyn T, Leszczynska D, Leszczynski J. Advancing risk assessment of engineered nanomaterials: application of computational approaches. Adv Drug Deliv Rev. 2012 Dec; 64(15):1663-93.
    View in: PubMed
    Score: 0.032
  18. Toropov AA, Toropova AP, Benfenati E, Gini G, Leszczynska D, Leszczynski J. SMILES-based QSAR approaches for carcinogenicity and anticancer activity: comparison of correlation weights for identical SMILES attributes. Anticancer Agents Med Chem. 2011 Dec; 11(10):974-82.
    View in: PubMed
    Score: 0.031
  19. Toropova AP, Toropov AA, Benfenati E, Gini G, Leszczynska D, Leszczynski J. CORAL: quantitative structure-activity relationship models for estimating toxicity of organic compounds in rats. J Comput Chem. 2011 Sep; 32(12):2727-33.
    View in: PubMed
    Score: 0.030
  20. Turabekova MA, Rasulev BF, Dzhakhangirov FN, Leszczynska D, Leszczynski J. Aconitum and Delphinium alkaloids of curare-like activity. QSAR analysis and molecular docking of alkaloids into AChBP. Eur J Med Chem. 2010 Sep; 45(9):3885-94.
    View in: PubMed
    Score: 0.028
  21. Puzyn T, Leszczynska D, Leszczynski J. Toward the development of "nano-QSARs": advances and challenges. Small. 2009 Nov; 5(22):2494-509.
    View in: PubMed
    Score: 0.027
  22. Toropov AA, Rasulev BF, Leszczynski J. QSAR modeling of acute toxicity by balance of correlations. Bioorg Med Chem. 2008 Jun 01; 16(11):5999-6008.
    View in: PubMed
    Score: 0.024
  23. Kuz'min VE, Muratov EN, Artemenko AG, Gorb L, Qasim M, Leszczynski J. The effects of characteristics of substituents on toxicity of the nitroaromatics: HiT QSAR study. J Comput Aided Mol Des. 2008 Oct; 22(10):747-59.
    View in: PubMed
    Score: 0.024
  24. Turabekova MA, Rasulev BF, Levkovich MG, Abdullaev ND, Leszczynski J. Aconitum and Delphinium sp. alkaloids as antagonist modulators of voltage-gated Na+ channels. AM1/DFT electronic structure investigations and QSAR studies. Comput Biol Chem. 2008 Apr; 32(2):88-101.
    View in: PubMed
    Score: 0.024
  25. Rasulev BF, Saidkhodzhaev AI, Nazrullaev SS, Akhmedkhodzhaeva KS, Khushbaktova ZA, Leszczynski J. Molecular modelling and QSAR analysis of the estrogenic activity of terpenoids isolated from Ferula plants. SAR QSAR Environ Res. 2007 Oct-Dec; 18(7-8):663-73.
    View in: PubMed
    Score: 0.023
  26. Wang J, Gu J, Leszczynski J. A model study of interactions between TcAChE peripheral site segment Tyr70Val71 and loop 1 of Fasciculin 2. J Biomol Struct Dyn. 2006 Oct; 24(2):139-48.
    View in: PubMed
    Score: 0.022
  27. Majumdar D, Roszak S, Leszczynski J. Probing the acetylcholinesterase inhibition of sarin: a comparative interaction study of the inhibitor and acetylcholine with a model enzyme cavity. J Phys Chem B. 2006 Jul 13; 110(27):13597-607.
    View in: PubMed
    Score: 0.022
  28. Isayev O, Rasulev B, Gorb L, Leszczynski J. Structure-toxicity relationships of nitroaromatic compounds. Mol Divers. 2006 May; 10(2):233-45.
    View in: PubMed
    Score: 0.021
  29. Wang J, Gu J, Leszczynski J. Hydrogen-bonding interactions in the binding of loop 1 of fasciculin 2 to Torpedo californica acetylcholinesterase: a density functional theory study. J Phys Chem B. 2005 Jul 21; 109(28):13761-9.
    View in: PubMed
    Score: 0.020
  30. Dyguda E, Grembecka J, Sokalski WA, Leszczynski J. Origins of the activity of PAL and LAP enzyme inhibitors: toward ab initio binding affinity prediction. J Am Chem Soc. 2005 Feb 16; 127(6):1658-9.
    View in: PubMed
    Score: 0.020
  31. Hoover G, Kar S, Guffey S, Leszczynski J, Sep?lveda MS. In?vitro and in silico modeling of perfluoroalkyl substances mixture toxicity in an amphibian fibroblast cell line. Chemosphere. 2019 Oct; 233:25-33.
    View in: PubMed
    Score: 0.013
  32. Golbamaki A, Golbamaki N, Sizochenko N, Rasulev B, Leszczynski J, Benfenati E. Genotoxicity induced by metal oxide nanoparticles: a weight of evidence study and effect of particle surface and electronic properties. Nanotoxicology. 2018 12; 12(10):1113-1129.
    View in: PubMed
    Score: 0.012
  33. Ba?ares MA, Haase A, Tran L, Lobaskin V, Oberd?rster G, Rallo R, Leszczynski J, Hoet P, Korenstein R, Hardy B, Puzyn T. CompNanoTox2015: novel perspectives from a European conference on computational nanotoxicology on predictive nanotoxicology. Nanotoxicology. 2017 Sep; 11(7):839-845.
    View in: PubMed
    Score: 0.012
  34. Golbamaki N, Rasulev B, Cassano A, Marchese Robinson RL, Benfenati E, Leszczynski J, Cronin MT. Genotoxicity of metal oxide nanomaterials: review of recent data and discussion of possible mechanisms. Nanoscale. 2015 Feb 14; 7(6):2154-98.
    View in: PubMed
    Score: 0.010
  35. He X, Aker WG, Leszczynski J, Hwang HM. Using a holistic approach to assess the impact of engineered nanomaterials inducing toxicity in aquatic systems. J Food Drug Anal. 2014 Mar; 22(1):128-146.
    View in: PubMed
    Score: 0.009
  36. Lubinski L, Urbaszek P, Gajewicz A, Cronin MT, Enoch SJ, Madden JC, Leszczynska D, Leszczynski J, Puzyn T. Evaluation criteria for the quality of published experimental data on nanomaterials and their usefulness for QSAR modelling. SAR QSAR Environ Res. 2013; 24(12):995-1008.
    View in: PubMed
    Score: 0.008
  37. Rasulev B, Kusic H, Leszczynska D, Leszczynski J, Koprivanac N. QSAR modeling of acute toxicity on mammals caused by aromatic compounds: the case study using oral LD50 for rats. J Environ Monit. 2010 May; 12(5):1037-44.
    View in: PubMed
    Score: 0.007
  38. Tchounwou PB, Newsome C, Glass K, Centeno JA, Leszczynski J, Bryant J, Okoh J, Ishaque A, Brower M. Environmental toxicology and health effects associated with dinitrotoluene exposure. Rev Environ Health. 2003 Jul-Sep; 18(3):203-29.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support